Molecular classification and immunotherapy in fertility-sparing treatment for endometrial cancer: opportunities and challenges - Top-Institutions - MDSpire

Molecular classification and immunotherapy in fertility-sparing treatment for endometrial cancer: opportunities and challenges

  • By

  • Jing Li

  • Shixiang Dong

  • Dongdong Hu

  • Wen Feng

  • July 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Gynecologic Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Gynecologic Oncology

  • #3

    University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

    Key Differentiators

    • Gynecologic Oncology

  • #4

    Leiden University Medical Centre
    Leiden University Medical Centre

    Leiden, Netherlands

    Key Differentiators

    • Gynecologic Oncology

  • #5

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Gynecologic Oncology

Original Source(s)

Molecular classification and immunotherapy in fertility-sparing treatment for endometrial cancer: opportunities and challenges

  • by Jing Li, Shixiang Dong, Dongdong Hu, Wen Feng

  • July 9, 2026

Related Content

Surfactant protein D: prognostic insights and emerging therapeutic roles in cancer

The use of motion tracking technology to support an exercise intervention for children and young people with cancer: perspectives of users and healthcare professionals in the FORTEe trial

Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets